Found: 1
Select item for more details and to access through your institution.
Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).
- Published in:
- Nutrients, 2024, v. 16, n. 15, p. 2545, doi. 10.3390/nu16152545
- By:
- Publication type:
- Article